Drug Development for Pediatric Populations: Regulatory Aspects.
about
Effect of propofol and remifentanil on cerebral perfusion and oxygenation in pigs: a systematic reviewNeonatal drug therapy: The first frontier of therapeutics for childrenPopulation pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing.Application of physiologically based pharmacokinetic modeling to predict acetaminophen metabolism and pharmacokinetics in childrenApproval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional studyNovel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases.Applications of accelerator MS in pediatric drug evaluation.Challenges and considerations for development of therapeutic proteins in pediatric patients.Physiologically based pharmacokinetic and pharmacodynamic modeling in cancer drug development: status, potential and gaps.Neonatal medicines research: challenges and opportunities.Quantitative clinical pharmacology for size and age scaling in pediatric drug development: A systematic review.A Comprehensive Review of Novel Drug-Disease Models in Diabetes Drug Development.Population pharmacokinetic analysis of a nevirapine-based HIV-1 prevention of mother-to-child transmission program in Uganda to assess the impact of different dosing regimens for newborns.Model-based assessment of dosing strategies in children for monoclonal antibodies exhibiting target-mediated drug dispositionSemi-Mechanistic Model for Predicting the Dosing Rate in Children and Neonates for Drugs Mainly Eliminated by Cytochrome Metabolism.Model Informed Pediatric Development Applied to Bilastine: Ontogenic PK Model Development, Dose Selection for First Time in Children and PK Study Design.Considerations for pediatric trial designs and analyses.Drugs Being Eliminated via the Same Pathway Will Not Always Require Similar Pediatric Dose Adjustments.Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank.Epinephrine in Anaphylaxis: Preclinical Study of Pharmacokinetics after Sublingual Administration of Taste-Masked Tablets for Potential Pediatric Use.
P2860
Q26743386-2D7BED66-2488-443F-B9D1-BB6F931E66FAQ27013749-E75B306E-18C7-4889-9B65-91C73F92FD37Q35130636-462F8162-A4E0-4041-A8EB-B869A99CF6E1Q37279407-E5913117-AEAD-438F-83C3-A1ADB16759C3Q37566655-EB832FB5-33F4-4751-B298-E2B6D6164F47Q37976848-B7AA5A96-9B0C-4506-979E-484724B201ECQ38040176-6B21A732-3E73-4CCC-99D6-F28130F708F3Q38364457-5B99CE2E-C2B5-45EC-9388-043266638B5CQ38458340-0BAE6445-56E1-47DA-9B00-0FDE94E5238FQ38469763-55529917-895B-479C-99EE-82E1C7E187D9Q38502414-EDE7A631-E5EC-4D31-870F-5A666EBC353AQ38707493-F0FA1890-C533-499E-8E7A-5CBE48FA1BF2Q38865904-F86E4179-AB44-4AF2-A38F-5C83D2964BC5Q41915506-C6AF646C-60F7-4A68-83F3-57FE5E731330Q47826980-6BCE88F3-1EA6-4449-8367-B7BFE6AAADB7Q47877945-DEA14CC9-FDCE-48CC-8513-1DF42CB5868AQ48034344-D542BA0F-CACD-455F-85B1-6F01004A3C0EQ49330212-BC3B7296-5A63-4290-9C81-C233263BBAC4Q50027860-6F4E83FF-D7F4-4CC6-ABC5-0ED72682717EQ50034090-1215B6D7-F6EA-4BA2-BA17-A1CABCCC4C85
P2860
Drug Development for Pediatric Populations: Regulatory Aspects.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Drug Development for Pediatric Populations: Regulatory Aspects.
@en
Drug Development for Pediatric Populations: Regulatory Aspects.
@nl
type
label
Drug Development for Pediatric Populations: Regulatory Aspects.
@en
Drug Development for Pediatric Populations: Regulatory Aspects.
@nl
prefLabel
Drug Development for Pediatric Populations: Regulatory Aspects.
@en
Drug Development for Pediatric Populations: Regulatory Aspects.
@nl
P2093
P2860
P1433
P1476
Drug Development for Pediatric Populations: Regulatory Aspects.
@en
P2093
Andreas Krause
Jasper Dingemanse
Jochen Zisowsky
P2860
P304
P356
10.3390/PHARMACEUTICS2040364
P577
2010-11-29T00:00:00Z